Similarly, glioma cell lines resistant to TRAIL were found to have a two-fold increase in PEA-15 expression and inhibition of PKC re-established sensitivity to TRAIL, implicating phosphorylation of PEA-15 in this process (Hao et al., 2001). The gene discussed is PEA15; the disease is central nervous system cancer.